Shopping Cart (0)
My Account

Shopping Cart
SELECTBIO Conferences The Space Summit 2022

Jennifer Fogarty's Biography

Jennifer Fogarty, Chief Scientific Officer, Translational Institute for Space Health, Baylor College of Medicine

Jennifer Fogarty, Ph.D. is the Chief Scientific Officer for the Translational Research Institute for Space Health (TRISH) at Baylor College of Medicine and the Director of Applied Health and Performance at Sophic Synergistics LLC. With more than twenty years of experience in medical physiology and human health and performance in extreme environments, her mission is to increase access to high-quality healthcare in space and on Earth, by empowering patients and medical providers with precision medicine and cutting-edge technology. As Chief Scientist of TRISH, Dr. Fogarty leads an innovative, high-risk research and development portfolio to address space exploration's most challenging human health and performance risks. In her role at Sophic Synergistics, a women-owned and led human-centered design firm, Dr. Fogarty guides a division focused on developing and expanding medical technologies for use in remote medicine, telemedicine, and home healthcare. As a former NASA Human Research Program Chief Scientist, Jennifer prioritized communication and collaboration between industry, academia, government, commercial spaceflight programs, and international partners. She continues to value and seek partnerships when assessing the fundamental and mechanistic discoveries that lead to innovative preventions and treatments to sustain health and performance.

Dr. Fogarty received her Ph.D. in Medical Sciences from Texas A&M University College of Medicine. Other appointments include Assistant Professor in both Baylor College of Medicine’s Center for Space Medicine and Department of Medicine; Editor of the Fundamentals of Aerospace Medicine, 4th and 5th editions; and Associate Editor for the journal npj Microgravity.

Jennifer Fogarty Image

Transforming the Future of Human Spaceflight with Bio-Engineered Autonomous Platforms

Monday, 7 November 2022 at 14:20

Add to Calendar ▼2022-11-07 14:20:002022-11-07 15:20:00Europe/LondonNASA TRISHThe Space Summit 2022 in Boston, USABoston,

Humans participating in space exploration will experience many health and performance challenges during space exploration missions. It is paramount that we identify biological vulnerabilities and areas of resilience so that we can design a crew health and performance system approach that protects the human and enables explorers to thrive during the journey, on a planetary surface, and as we become a multiplanetary species. The Translational Research Institute for Space Health (TRISH) is chartered to find and fund cutting edge high-risk research and technology development to address the risks and challenges of human spaceflight. One of the most challenging aspects of doing research on the human risks associated with deep space exploration is having tools that accurately and efficiently reveal the resilience and vulnerabilities we seek to identify without putting humans directly at risk. Bio-engineered platforms such as tissue chips (microphysiological systems) and organoids represent cutting edge approaches to research and personalized medicine that meet space explorations needs. The progressive maturation and validation of these platforms establishes them as necessary tools to conduct biological research and establish personalized preventive and treatment therapies. To become operationally relevant in the constrained and extreme environments associated with space exploration these platforms must become automated. This phase of development will require new approaches to biomarker signal detection and quantification while we continue to build the evidence base to allow interpretation and most importantly actionable results.

Add to Calendar ▼2022-11-07 00:00:002022-11-08 00:00:00Europe/LondonThe Space Summit 2022The Space Summit 2022 in Boston, USABoston,